Dbv Technologies operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Dbv Technologies with three other
companies in this sector in France:
sales of 3.48 million Euro [US$3.82 million]
of which 88%
was Orphan Products Oncology),
(9.96 million Euro [US$10.94 million]
of which 100%
was Sale of Pharmaceuticals), and
(2.46 million Euro [US$2.70 million]
Dbv Technologies reported sales of 6.17 million Euro (US$6.77 million)
December of 2015.
increase of 29.5%
versus 2014, when the company's sales were 4.76 million Euro.
This was the fourth straight year of sales growth at Dbv Technologies.